Proteomics International Laboratories Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.02 |
Market Cap |
AUD26.63 M |
Shares Outstanding |
80.1 M |
Public Float |
- |
Address |
QEII Medical Centre Perth Western Australia (WA) 6009 Australia |
Employees | - |
Website | http://www.proteomics.com.au |
Updated | 07/08/2019 |
Proteomics International Laboratories Ltd. is a biological research and drug discovery company. It operates through three synergistic business units: Analytical services, Diagnostics and Therapeutics. The Analytical services unit engages in contract research, analytical testing and consultancy. |